Skip to main content
  • Connect with Us
Home

Search form

  • Home
    • About Us
  • Membership
  • GCIG Roster
  • Chicago 2020
  • Past Meetings
    • Athens 2019
    • Chicago 2019
    • Munich 2018
    • Chicago 2018
    • Vienna 2017
    • Chicago 2017
    • Lisbon 2016
    • Chicago 2016
    • Japan 2015
    • Chicago 2015
    • Melbourne 2014
    • Chicago 2014
    • London 2013
    • Chicago 2013
    • Leiden 2012
    • Chicago 2012
    • Milan 2011
  • Calendar
    • Event Listing
  • CA 125 Response Definition
  • GCIG Clinical Trials
  • Bibliography
  • CCRN Committee
    • GCIG CCRN Education Symposium, Johannesburg, January 2019
    • GCIG CCRN Education Symposium, Bucharest, January 2018
    • GCIG CCRN Education Symposium, Mexico, January 2017
    • GCIG CCRN Education Symposium, Bangkok, January 2016
  • Clinical Q&A
  • Educational Symposia
  • GCIG Pathology
  • Advocacy
  • Harmonization
Home /Biblio

Biblio

Found 2 results
[ Author(Asc)] Keyword Title Type Year
Filters: First Letter Of Last Name is N  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
N
H. Nomura, Aoki, D., Takahashi, F., Katsumata, N., Watanabe, Y., Konishi, I., Jobo, T., Hatae, M., Hiura, M., and Yaegashi, N., “Randomized phase II study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma: a Japanese Gynecologic Oncology Group study (JGOG2041).”, Ann Oncol, vol. 22, no. 3, pp. 636-42, 2011.
G. Newman, “ICON4/AGO-OVAR-2.2: questions about trial design, cost-effectiveness, and clinical benefit”, Lancet, vol. 362, p. 1333; author reply 1334, 2003.